Opioid Epidemic

The FDA has a key role to play in combating America's overdose epidemic, but advocacy groups debate whether it's doing enough.

It's not just drug manufacturers who are feeling the effects of major opioid lawsuits.

The charges mean that two former Rochester Drug Company leaders could face prison time.

Doctors are caught in an illicit opioid scheme, Washington State moves toward renewable energy, and a fireball lights up the Mid-Atlantic.

Legal evidence is needed to pin addiction and death on opioid manufacturers, but the science suggests that a large and ready supply of legal prescription painkillers led to many addictions.

New research suggests the provision allowing people to stay on their parents' health insurance means more young people are getting treatment.

This is the biggest state opioid settlement yet, and lawyers and addiction patients' advocates are waiting eagerly to see what precedent it will set.

Between 2011 and 2016, drug overdose deaths in the United States involving the synthetic opioid fentanyl dramatically increased, according to a report released Thursday.

A new major report finds that laws around medication for opioid addiction aren't based in science.

OxyContin's maker contemplates bankruptcy, anti-abortion bills move forward in Georgia and Tennessee, and women will take a walk in space.

The popular notion of the opioid crisis primarily affecting rural communities does not hold up, according to new research.

In a sealed court document, one of the company's controlling members indicated that Purdue Pharma should not correct misconceptions about the strength of oxycodone.

New research finds use of painkillers more than doubles the risk that a driver will set into motion a fatal two-car crash.

The maker of the potent painkiller Oxycontin discussed how the sale of opioids and the treatment of opioid addiction were "naturally linked."

In a new book, White House staffer Cliff Sims recounts what the president wanted for White House-sponsored ads intended to discourage young Americans from abusing opioid painkillers.

A new study suggests drug-company practices helped create the current epidemic.

The Food and Drug Administration is approving a powerful new opioid painkiller, the agency announced Friday.

The declaration was met with a lot of fanfare, but officials did little with the legal powers it gave them, experts say.

A new study asks if insurance policies discourage the overprescribing of opioids and encourage proven alternative pain treatments.

There are real reasons to debate whether it's worth opening these facilities in communities, but Deputy Attorney General Rod Rosenstein instead relies on unscientific fear-mongering.

The proposal follows several other efforts to combat the ongoing epidemic on both the state and federal levels—some more effective than others.

Officials hope to curb overdoses that they think are caused by the overprescription of opioid painkillers to chronic pain patients.

A study shows that people feel differently about "overdose prevention sites" and "safe consumption sites."

After the 2014 rule change, sales of prescription painkillers went up among U.S. sellers on dark Web marketplaces.